Suppr超能文献

膝关节细胞种植自体软骨细胞移植的临床疗效:何时可预测成败?

Clinical outcomes after cell-seeded autologous chondrocyte implantation of the knee: when can success or failure be predicted?

机构信息

Jan M. Pestka, Department of Orthopedic Surgery and Traumatology, Freiburg University Hospital, Hugstetter Str. 55, D - 79095 Freiburg, Germany.

出版信息

Am J Sports Med. 2014 Jan;42(1):208-15. doi: 10.1177/0363546513507768. Epub 2013 Oct 28.

Abstract

BACKGROUND

Autologous chondrocyte implantation (ACI) has been associated with satisfying results. Still, it remains unclear when success or failure after ACI can be estimated.

PURPOSE

To evaluate the clinical outcomes of cell-seeded collagen matrix-supported ACI (ACI-Cs) for the treatment of cartilage defects of the knee at 36 months and to determine a time point after ACI-Cs at which success or failure can be estimated.

STUDY DESIGN

Cohort study; Level of evidence, 3.

METHODS

A total of 80 patients with isolated full-thickness cartilage defects of the knee joint treated with ACI-Cs were prospectively assessed before surgery as well as postoperatively by use of the International Knee Documentation Committee (IKDC) score and Lysholm knee score.

RESULTS

Preoperative IKDC and Lysholm scores increased from 49.6 and 59.5, respectively, to 79.1 and 83.5, respectively, at 36 months. Only half the patients (46.6%) with poor IKDC scores (ie, <70) at 6 months postoperatively showed continued poor or fair scores at 36 months' follow-up. The probability of poor scores at 36 months after surgery further increased to 0.61 and 0.81, respectively, when scores were persistent at 12 and 24 months. All 3 patients (100%) with good IKDC scores (ie, 81-90) at 6 months after surgery showed constant or even improved scores at 36 months' follow-up. Ninety-one percent of patients with good and excellent scores at 12 months and 83% of patients with good and excellent scores at 24 months (a total of 23 and 37 patients, respectively) were able to maintain these scores at 36 months' follow-up. Similar results were obtained for the Lysholm score.

CONCLUSION

With regard to the improvements in functional outcomes after ACI-Cs at 36 months after surgery, the technique described here appears to lead to satisfying and stable clinical results. This study helps the treating physician to predict the likeliness of further clinical improvements or constant unsatisfactory results after ACI. In patients with good/excellent scores shortly after surgery, deterioration of the knee's condition is rarely found. For patients with poor and fair postoperative scores, clinical outcomes are more difficult to predict, especially during the first year after the procedure.

摘要

背景

自体软骨细胞移植(ACI)已取得令人满意的效果,但对于 ACI 后何时可以评估成功或失败仍不明确。

目的

评估细胞接种胶原基质支持的 ACI(ACI-Cs)治疗膝关节软骨缺损的 36 个月临床结果,并确定 ACI-Cs 后可以评估成功或失败的时间点。

研究设计

队列研究;证据水平,3 级。

方法

前瞻性评估 80 例接受 ACI-Cs 治疗的膝关节全层软骨缺损患者,术前及术后采用国际膝关节文献委员会(IKDC)评分和 Lysholm 膝关节评分进行评估。

结果

术前 IKDC 和 Lysholm 评分分别从 49.6 和 59.5 增加到 36 个月时的 79.1 和 83.5。只有一半(46.6%)的患者术后 6 个月 IKDC 评分(即<70)较差,在 36 个月随访时仍表现为较差或一般评分。术后 36 个月时,评分持续 12 个月和 24 个月时,评分较差的概率分别进一步增加至 0.61 和 0.81。术后 6 个月时所有(100%)IKDC 评分良好(即 81-90)的 3 例患者在 36 个月随访时均表现为稳定或甚至改善的评分。12 个月时 91%(共 23 例)和 24 个月时 83%(共 37 例)的患者评分良好和优秀的患者在 36 个月随访时仍能保持这些评分。Lysholm 评分也得到了类似的结果。

结论

就 ACI-Cs 术后 36 个月的功能结果改善而言,本研究中描述的技术似乎可带来令人满意且稳定的临床结果。本研究有助于治疗医生预测 ACI 后进一步临床改善或持续不满意结果的可能性。术后短期内评分良好/优秀的患者,膝关节状况很少恶化。对于术后评分较差和一般的患者,临床结果更难预测,尤其是在术后的前 1 年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验